Laurion Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-42,813
Closed -$191K 655
2021
Q1
$191K Buy
+42,813
New +$191K ﹤0.01% 484